Abdulkader Puranwala
Stock Analyst at ICICI Securities
(3.17)
# 2,522
Out of 4,478 analysts
40
Total ratings
69.2%
Success rate
7.8%
Average return
Main Sectors:
Stocks Rated by Abdulkader Puranwala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Buy | ₹6,065 → ₹6,850 | $5,598.50 | +22.35% | 4 | May 28, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹8,840 → ₹8,820 | $8,872.00 | -0.59% | 3 | Feb 12, 2026 | |
| NSE: GLENMARK Glenmark Pharmaceuticals Limited | Maintained: Sell | ₹1,570 → ₹1,640 | $2,270.90 | -27.78% | 3 | Feb 3, 2026 | |
| NSE: GLAND Gland Pharma Limited | Maintained: Buy | ₹2,115 → ₹2,275 | $2,463.20 | -7.64% | 2 | Jan 29, 2026 | |
| NSE: AKUMS Akums Drugs and Pharmaceuticals Limited | Maintained: Buy | ₹655.00 → ₹600.00 | $622.00 | -3.54% | 3 | Dec 22, 2025 | |
| NSE: SUNPHARMA Sun Pharmaceutical Industries Limited | Maintained: Buy | ₹1,800 → ₹1,965 | $1,912.80 | +2.73% | 2 | Nov 6, 2025 | |
| NSE: NATCOPHARM NATCO Pharma Limited | Maintained: Sell | ₹890.00 → ₹810.00 | $928.20 | -12.73% | 2 | Aug 14, 2025 | |
| NSE: METROPOLIS Metropolis Healthcare Limited | Maintained: Buy | ₹600.00 | $572.00 | +4.90% | 1 | Aug 11, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Upgraded: Hold | ₹855.00 | $980.05 | -12.76% | 1 | Aug 8, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Downgraded: Sell | ₹630.00 | $823.75 | -23.52% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹5,400 | $6,857.50 | -21.25% | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,110 → ₹1,950 | $2,490.00 | -21.69% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹900.00 | $835.65 | +7.70% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,445 → ₹1,300 | $1,593.10 | -18.40% | 2 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹590.00 | $651.85 | -9.49% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,900 → ₹1,500 | $1,692.00 | -11.35% | 2 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,000 | $1,352.80 | -26.08% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹910.00 → ₹486.62 | $544.60 | -10.65% | 2 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,200 | $1,364.60 | -12.06% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,400 | $450.00 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,250 | $2,402.20 | n/a | 1 | Feb 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,000 | $1,147.90 | n/a | 1 | Feb 6, 2025 |
Alkem Laboratories Limited
May 28, 2026
Maintained: Buy
Price Target: ₹6,065 → ₹6,850
Current: $5,598.50
Upside: +22.35%
Apollo Hospitals Enterprise Limited
Feb 12, 2026
Maintained: Buy
Price Target: ₹8,840 → ₹8,820
Current: $8,872.00
Upside: -0.59%
Glenmark Pharmaceuticals Limited
Feb 3, 2026
Maintained: Sell
Price Target: ₹1,570 → ₹1,640
Current: $2,270.90
Upside: -27.78%
Gland Pharma Limited
Jan 29, 2026
Maintained: Buy
Price Target: ₹2,115 → ₹2,275
Current: $2,463.20
Upside: -7.64%
Akums Drugs and Pharmaceuticals Limited
Dec 22, 2025
Maintained: Buy
Price Target: ₹655.00 → ₹600.00
Current: $622.00
Upside: -3.54%
Sun Pharmaceutical Industries Limited
Nov 6, 2025
Maintained: Buy
Price Target: ₹1,800 → ₹1,965
Current: $1,912.80
Upside: +2.73%
NATCO Pharma Limited
Aug 14, 2025
Maintained: Sell
Price Target: ₹890.00 → ₹810.00
Current: $928.20
Upside: -12.73%
Metropolis Healthcare Limited
Aug 11, 2025
Maintained: Buy
Price Target: ₹600.00
Current: $572.00
Upside: +4.90%
Fortis Healthcare Limited
Aug 8, 2025
Upgraded: Hold
Price Target: ₹855.00
Current: $980.05
Upside: -12.76%
Krishna Institute of Medical Sciences Limited
Aug 8, 2025
Downgraded: Sell
Price Target: ₹630.00
Current: $823.75
Upside: -23.52%
Aug 7, 2025
Maintained: Sell
Price Target: ₹5,400
Current: $6,857.50
Upside: -21.25%
Aug 7, 2025
Maintained: Hold
Price Target: ₹2,110 → ₹1,950
Current: $2,490.00
Upside: -21.69%
Aug 6, 2025
Maintained: Hold
Price Target: ₹900.00
Current: $835.65
Upside: +7.70%
Aug 6, 2025
Upgraded: Buy
Price Target: ₹1,445 → ₹1,300
Current: $1,593.10
Upside: -18.40%
Aug 5, 2025
Maintained: Hold
Price Target: ₹590.00
Current: $651.85
Upside: -9.49%
Aug 1, 2025
Maintained: Hold
Price Target: ₹2,900 → ₹1,500
Current: $1,692.00
Upside: -11.35%
Jul 29, 2025
Maintained: Sell
Price Target: ₹1,000
Current: $1,352.80
Upside: -26.08%
Jul 25, 2025
Maintained: Buy
Price Target: ₹910.00 → ₹486.62
Current: $544.60
Upside: -10.65%
Jul 24, 2025
Maintained: Hold
Price Target: ₹1,200
Current: $1,364.60
Upside: -12.06%
Mar 25, 2025
Initiated Coverage: Buy
Price Target: ₹1,400
Current: $450.00
Upside: n/a
Feb 17, 2025
Upgraded: Buy
Price Target: ₹2,250
Current: $2,402.20
Upside: n/a
Feb 6, 2025
Maintained: Hold
Price Target: ₹1,000
Current: $1,147.90
Upside: n/a